Cargando…
Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259665/ https://www.ncbi.nlm.nih.gov/pubmed/37040265 http://dx.doi.org/10.1002/cac2.12418 |
| _version_ | 1785057707359731712 |
|---|---|
| author | Li, Jin Yang, Jianhua Shou, Huafeng Zhang, Lin Huang, Xiaohong Tang, Xuedong Zheng, Fei Liu, Fang Wen, Hao Yang, Huijuan Wang, Huaying Li, Ziting Chen, Xiaojun Ju, Xingzhu Cheng, Xi Tang, Jie Zhang, Meiqin Wu, Xiaohua |
| author_facet | Li, Jin Yang, Jianhua Shou, Huafeng Zhang, Lin Huang, Xiaohong Tang, Xuedong Zheng, Fei Liu, Fang Wen, Hao Yang, Huijuan Wang, Huaying Li, Ziting Chen, Xiaojun Ju, Xingzhu Cheng, Xi Tang, Jie Zhang, Meiqin Wu, Xiaohua |
| author_sort | Li, Jin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10259665 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102596652023-06-13 Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China Li, Jin Yang, Jianhua Shou, Huafeng Zhang, Lin Huang, Xiaohong Tang, Xuedong Zheng, Fei Liu, Fang Wen, Hao Yang, Huijuan Wang, Huaying Li, Ziting Chen, Xiaojun Ju, Xingzhu Cheng, Xi Tang, Jie Zhang, Meiqin Wu, Xiaohua Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2023-04-11 /pmc/articles/PMC10259665/ /pubmed/37040265 http://dx.doi.org/10.1002/cac2.12418 Text en © 2023 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Li, Jin Yang, Jianhua Shou, Huafeng Zhang, Lin Huang, Xiaohong Tang, Xuedong Zheng, Fei Liu, Fang Wen, Hao Yang, Huijuan Wang, Huaying Li, Ziting Chen, Xiaojun Ju, Xingzhu Cheng, Xi Tang, Jie Zhang, Meiqin Wu, Xiaohua Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China |
| title | Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China |
| title_full | Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China |
| title_fullStr | Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China |
| title_full_unstemmed | Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China |
| title_short | Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China |
| title_sort | real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in china |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259665/ https://www.ncbi.nlm.nih.gov/pubmed/37040265 http://dx.doi.org/10.1002/cac2.12418 |
| work_keys_str_mv | AT lijin realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT yangjianhua realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT shouhuafeng realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT zhanglin realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT huangxiaohong realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT tangxuedong realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT zhengfei realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT liufang realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT wenhao realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT yanghuijuan realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT wanghuaying realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT liziting realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT chenxiaojun realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT juxingzhu realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT chengxi realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT tangjie realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT zhangmeiqin realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina AT wuxiaohua realworldoutcomesofniraparibtreatmentinpatientswithovariancanceramulticenternoninterventionalstudyinchina |